Longitudinal Impact of Antihypertensive Polypharmacy on Geriatric Syndromes

抗高血压多药治疗对老年综合征的纵向影响

• 批准号: 8133180
• 负责人: JOSEPH T HANLON
• 金额: $ 24.2万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8133180
• 关键词: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adverse effects; Affect; Age; Aging; Angiotensin Receptor; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area; Behavioral Genetics; Biological Preservation; Blood Pressure; Body Composition; Calcium Channel Blockers; Clinical; Cohort Studies; Communities; Comorbidity; Data; Databases; Development; Disease; Diuretics; Elderly; Epidemiologic Studies; Equilibrium; Funding; Future; Gait; Gender; Geriatrics; Gerontology; Guidelines; Health; Health Care Costs; Hypertension; Impaired cognition; Intervention; Investigation; Knowledge; Lead; Life; Link; Lower Extremity; Measures; National Institute on Aging; Neuraxis; Outcome; Participant; Pathway interactions; Patient Self-Report; Pennsylvania; Performance; Personal Communication; Pharmaceutical Preparations; Polypharmacy; Population; Race; Recurrence; Research; Research Priority; Risk; Risk Factors; Risk-Taking; Sampling; Speed; Syndrome; Tennessee; Testing; Time; Urinary Incontinence; Vasodilator Agents; Woman; Work; cognitive function; cost effective; disability; dosage; falls; follow-up; improved; longitudinal design; men; mental state; modifiable risk; mortality; multiple drug use; performance tests; population based; programs; public health relevance; racial difference; time interval; trend